Skip to main content

Animations

MJFF Publications

3111 - 3120 of 8654 Results
Title
Year
  • Year
  • 2019
  • 2025
  • 2018
  • 2018
  • 2019
  • 2019
  • 2024
  • 2013
  • 2014
  • 2014
  • Summary Details
    OPEN
    Title: Motor phenotype classification in moderate to advanced PD in BioFIND study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.017
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Network spreading and local biological vulnerability in amyotrophic lateral sclerosis
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-025-08561-3
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A novel extended form of alpha-synuclein 3′UTR in the human brain
    Journal Name: Molecular Brain
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13041-018-0371-x
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Heritability estimates of cortical anatomy: The influence and reliability of different estimation strategies
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2018.05.014
    Citation Count: 21
  • Summary Details
    RESTRICTED
    Title: Artificial Neural Network–Based Prediction of Outcome in Parkinson’s Disease Patients Using DaTscan SPECT Imaging Features
    Journal Name: Molecular Imaging and Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11307-019-01334-5
    Best OA location URL:
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2019.101986
    Citation Count: 40
  • Summary Details
    OPEN
    Title: A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00624-8
    Citation Count: 15
  • Summary Details
    OPEN
    Title: PKCδ mediates paraquat-induced Nox1 expression in dopaminergic neurons
    Journal Name: Biochemical and Biophysical Research Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbrc.2013.06.085
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.10.029
    Citation Count: 147
  • Summary Details
    OPEN
    Title: Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.047
    Citation Count: 22
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.